Dr. Giorgio Casaburi is a bioinformatics scientist and translational genomics researcher specializing in artificial intelligence, multi-omics data integration, and precision medicine. His work focuses on developing clinically actionable molecular diagnostics and computational platforms that translate complex biological data into real-world healthcare applications.

Dr. Casaburi has over 15 years of experience leading genomics, transcriptomics, methylomics, metagenomics, and machine learning initiatives across academia, biotechnology, and regulated diagnostics environments. His research spans cancer biology, microbiome science, biomarker discovery, translational AI, and predictive modeling for therapeutic response and disease stratification.

He has led the development and validation of multiple AI-driven diagnostic and bioinformatics platforms, including CLIA-oriented molecular workflows and clinical decision-support systems. His work integrates next-generation sequencing, cloud-scale bioinformatics infrastructure, and machine learning approaches to accelerate translational research and precision oncology applications.

Prior to joining USC, Dr. Casaburi held leadership roles in biotechnology and molecular diagnostics organizations, including SOLVD Health, Exagen, Prescient Metabiomics, and Evolve Biosystems. He has authored more than 70 peer-reviewed publications, contributed to multiple patents in diagnostics and AI-enabled healthcare technologies, and has presented research at major international scientific conferences.

At USC, his academic interests include translational genomics, AI-driven biomedical research, computational oncology, and the application of machine learning to molecular diagnostics and precision medicine.